Hemogenyx Pharmaceuticals Debt 2024

Hemogenyx Pharmaceuticals Aktienanalyse

What does Hemogenyx Pharmaceuticals do?

Hemogenyx Pharmaceuticals PLC is a biotechnology company based in London that develops therapies based on human blood stem cells. The company focuses on developing therapies in three areas: CAR-T cell therapy, blood stem cell therapy, and cell therapy to support immune defense. Hemogenyx has already developed several products and has partnerships with institutions such as the University of Edinburgh. The company went public in 2018 and has invested heavily in the development of new therapies. Hemogenyx Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Hemogenyx Pharmaceuticals's Debt Structure

Hemogenyx Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Hemogenyx Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Hemogenyx Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Hemogenyx Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Hemogenyx Pharmaceuticals Stock

What is the debt of Hemogenyx Pharmaceuticals this year?

Hemogenyx Pharmaceuticals has a debt level of 1.7 GBP this year.

What was the debt of Hemogenyx Pharmaceuticals compared to the previous year?

The debt of Hemogenyx Pharmaceuticals has increased by 90.8% compared to the previous year increased.

What are the consequences of high debt for investors in Hemogenyx Pharmaceuticals?

High debt can pose a risk for investors of Hemogenyx Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Hemogenyx Pharmaceuticals?

Low debt means that Hemogenyx Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Hemogenyx Pharmaceuticals affect the company?

An increase in debt of Hemogenyx Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Hemogenyx Pharmaceuticals affect the company?

A reduction in debt of Hemogenyx Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Hemogenyx Pharmaceuticals?

Some factors that can influence the debt of Hemogenyx Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Hemogenyx Pharmaceuticals so important for investors?

The debts of Hemogenyx Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Hemogenyx Pharmaceuticals take to change the debt?

To change the debt, Hemogenyx Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Hemogenyx Pharmaceuticals pay?

Over the past 12 months, Hemogenyx Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hemogenyx Pharmaceuticals is expected to pay a dividend of 0 GBP.

What is the dividend yield of Hemogenyx Pharmaceuticals?

The current dividend yield of Hemogenyx Pharmaceuticals is .

When does Hemogenyx Pharmaceuticals pay dividends?

Hemogenyx Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hemogenyx Pharmaceuticals?

Hemogenyx Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Hemogenyx Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hemogenyx Pharmaceuticals located?

Hemogenyx Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hemogenyx Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hemogenyx Pharmaceuticals from 6/26/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Hemogenyx Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Hemogenyx Pharmaceuticals in the year 2023?

In the year 2023, Hemogenyx Pharmaceuticals distributed 0 GBP as dividends.

In which currency does Hemogenyx Pharmaceuticals pay out the dividend?

The dividends of Hemogenyx Pharmaceuticals are distributed in GBP.